67
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Commentary: Is Polyethylene Glycol Toxicity From Intravenous Methocarbamol Fact or Fiction?

, & ORCID Icon
Pages 180-184 | Received 31 Oct 2023, Accepted 16 Apr 2024, Published online: 08 May 2024

References

  • West-Ward Pharmaceuticals Corp. Robaxin [package insert]. U.S. National Library of Medicine DailyMed database; 2018 [Revised Dec 2018; cited 14 Sep 2023]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=090a3d3d-92c3-4c30-a648-436461f81702.
  • See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008;28(2):207–13. doi:10.1592/phco.28.2.207.
  • Agency for Healthcare Research and Quality. Medical expenditure panel survey 2013–2021. Agency for Healthcare Research and Quality, Rockville, MD. ClinCalc DrugStats Database version 2024.01 (cited 4 Jan 2024). Available from: https://clincalc.com/DrugStats/Top300Drugs.aspx.
  • Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain – United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. doi:10.15585/mmwr.rr7103a1.
  • Price JC. Polyethylene glycol. In: Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients. 5th ed. Washington D.C.: American Pharmacists Association; 2006. p. 545–9.
  • Gullapalli RP, Mazzitelli CL. Polyethylene glycols in oral and parenteral formulations–a critical review. Int J Pharm. 2015;496(2):219–39. doi:10.1016/j.ijpharm.2015.11.015.
  • Nordt SP, Vivero LE. Pharmaceutical additives. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank’s toxicologic emergencies [e-book]. 12th ed. New York: McGraw Hill Medical; 2022.
  • DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod VL, Posey LM, editors. DiPiro’s pharmacotherapy: a pathophysiologic approach [e-book]. 12th ed. New York: McGraw Hill; 2022.
  • Wargo KA, Centor RM. ABCs of ABGs: a guide to interpreting acid-base disorders. Hosp Pharm. 2008;43(10):808–18. doi:10.1310/hpj4310-808.
  • DuBose TD. Acidosis and alkalosis. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL, editors. Harrison’s principles of internal medicine. 21st ed. New York: McGraw Hill; 2022.
  • Levin A, Stevens PE, Bilous RW, Coresh J, De Franscisco ALM, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150. doi:10.1038/kisup.2012.73.
  • Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77. doi:10.1007/s00134-017-4683-6.
  • Laine GA, Hossain SM, Solis RT, Adams SC. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother. 1995;29(11):1110–4. doi:10.1177/106002809502901107.
  • Tayar J, Jabbour G, Saggi SJ. Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med. 2002;346(16):1253–4. doi:10.1056/NEJM200204183461618.
  • Owen SC, Weller PJ. Propylene glycol. In: Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients. 5th ed. Washington D.C.: American Pharmacists Association; 2006. p. 624–6.
  • Cate JC, Hedrick R. Propylene glycol intoxication and lactic acidosis. N Engl J Med. 1980;303(21):1237. doi:10.1056/NEJM198011203032116.
  • Neale BW, Mesler EL, Young M, Rebuck JA, Weise WJ. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Ann Pharmacother. 2005;39(10):1732–6. doi:10.1345/aph.1G083.
  • Herold DA, Rodeheaver GT, Bellamy WT, Fitton LA, Bruns DE, Edlich RF. Toxicity of topical polyethylene glycol. Toxicol Appl Pharmacol. 1982;65(2):329–35. doi:10.1016/0041-008x(82)90016-3.
  • Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet. 2008;47(10):635–54. doi:10.2165/00003088-200847100-00002.
  • Pham Le Khanh H, Nemes D, Rusznyák Á, Ujhelyi Z, Fehér P, et al. Comparative investigation of cellular effects of polyethylene glycol (PEG) derivatives. Polymers. 2022;14(2):279. doi:10.3390/polym14020279.
  • McCabe WR. Treatment of chronic pyelonephritis. AMA Arch Intern Med. 1959;104(5):710. doi:10.1001/archinte.1959.00270110030004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.